Deferred Tax Assets, Valuation Allowance of TG THERAPEUTICS, INC. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
TG THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • TG THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $39,977,000, a 90% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

TG THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $39,977,000 -$374,637,000 -90% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q4 2024 $414,614,000 -$3,703,000 -0.88% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q4 2023 $418,317,000 +$17,954,000 +4.5% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q4 2022 $400,363,000 +$32,917,000 +9% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $367,446,000 +$90,743,000 +33% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $276,703,000 +$89,992,000 +48% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $186,711,000 +$43,764,000 +31% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $142,947,000 +$43,234,000 +43% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $99,713,000 -$16,458,829 -14% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q4 2016 $116,171,829 +$29,812,979 +35% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $86,358,850 +$17,275,081 +25% 31 Dec 2015 10-K 15 Mar 2018 2017 FY
Q4 2014 $69,083,769 +$22,800,769 +49% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q4 2013 $46,283,000 +$10,012,077 +28% 31 Dec 2013 10-K 15 Mar 2016 2015 FY
Q4 2012 $36,270,923 +$6,862,923 +23% 31 Dec 2012 10-K 07 Mar 2014 2013 FY
Q4 2011 $29,408,000 31 Dec 2011 10-K 21 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.